As of last week, BIGZ is now the BlackRock Technology and Private Equity Term Trust (BTX), a fund that will be half its size in June when a Tender Offer will cash out 50% of outstanding shares at ...

The company’s lead clinical candidate, BTX-A51, is an oral small molecule, multi-kinase inhibitor designed to block a specific leukemic stem cell target (CK1α) as well as super enhancer targets ...

But with BTX now down to $7.75 after the name/ticker change yesterday, it's becoming attractive once again. The problem is that we don't know what the new NAV symbol for BTX is, so it's hard to ...

Most pain treatments are not localized to a specific region or cell type and thus require relatively large ... The naturally occurring Botulinum Neurotoxin A (BTX-A) has proven highly beneficial for ...

It offers IRX-2, a human cell-derived cytokine therapy, studying the safety and efficacy of IRX-2 in patients with head and neck cancer in Phase 2B. Receive News & Ratings for Brooklyn ...